Assembly Biosciences Inc (ASMB) Annual Balance Sheets

Annual · GAAP · USD millions
Access ASMB quarterly Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Assembly Biosciences Inc manages assets, liabilities, and equity through different cycles.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent58.45
Available-for-sale Securities, Debt Securities, Current MA189.66
Cash & Short-term Investments247.00
Accounts receivable0.97
Prepaid Expense And Other Assets Current5.47
Total Current Assets254.55
Equipment/Property/Plant Net0.22
Long-term investments0.00
Other Assets, Noncurrent2.82
Operating Lease Right Of Use Asset2.51
Total Assets257.59
Liabilities
Accounts Payable, Current AC1.17
Other Accrued Liabilities, Current7.75
Other Liabilities, Current39.86
Total Current Liabilities48.78
Total Long-term Debt0.00
Other liabilities, Noncurrent2.06
OperatingLeaseLiabilityNoncurrent2.06
Accrued Research And Development Expenses Current2.39
Operating Lease Liability Current0.57
Total Liabilities50.84
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock1,038.82
Retained Earnings / Accumulated Deficit-832.05
Other Equity-0.04
Common Stockholder's Equity206.75
Total Stockholder's Equity206.75
Liabilities & Stockholder's Equity257.59
4 historic quarters locked

Sign in to unlock the full Assembly Biosciences Inc balance sheet history.

About Assembly Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-115992

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.